MarketPulse

buprenorphine

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Indivior Pharmaceuticals, Inc.

Indivior's Buprenorphine Data Shows Lowest Overdose Rates Among OUD Treatments

Indivior reports SUBLOCADE injectable buprenorphine shows lowest overdose rates among OUD treatments, with data supporting remission as meaningful outcome.
INDVbuprenorphineSUBLOCADE
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Indivior Signals Q1 2026 Results as SUBLOCADE Gains Ground in Correctional Care

$INDV to report Q1 2026 earnings April 30, highlighting SUBLOCADE's cost-reduction potential in correctional facilities amid opioid crisis.
INDVfinancial resultscost reduction
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Collegium to Showcase Real-World Pain Drug Data at 2026 Medical Conference

Collegium Pharmaceutical to present real-world clinical data on pain medication BELBUCA at major medical conference in March 2026.
COLLclinical evidenceCollegium Pharmaceutical